Skin Cancer Screening Education Study | NCT02352428 | Trialant

Skin Cancer Screening Education Study | NCT02352428 | Trialant

Sponsor/Collaborators Module

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Skin Cancer Screening Training	Experimental	Recruited family physicians and dermatologists in Calgary, Canada, take part in a 5.5-hour face-to-face skin cancer screening training program. Screening for skin cancer will be conducted by trained physicians according to instructions they received in the training program.	Other: Skin Cancer Screening Training
No Skin Cancer Screening Training	No Intervention	Recruited family physicians and dermatologists in Edmonton, Canada, WILL BE TRAINED AFTER THE SCREENING PHASE, i.e. during the screening phase non-trained physicians will carry out skin cancer screenings according to standard medical practice.

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Skin Cancer Screening Training	Other	Topics of the 5.5-hour in-class course include: the screening test, types of skin cancer (signs and symptoms), case history taking, epidemiology of skin cancer, etiology, risk factors and risk groups, communicative aspects of primary and secondary preventive measures, and benefits and harms of cancer screenings.

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Change in the diagnostic accuracy including knowledge on skin cancer screening	Educational outcomes of physicians will be measured pre- and post-training using knowledge tests in the intervention and control region	month 1 pre-training (intervention and control region), month 1 post-training (intervention region only), and month 12 (both regions)
Number needed to screen (NNS) to identify 1 skin tumor and number needed to excise (NNE) to identify 1 skin tumor	Case report forms will be analyzed to determine clinical screening outcomes such as the NNS, NNE and tumor thickness.	20 months
Patient-rated well-being	A patient questionnaire will be used to assess psycho-social harms of skin cancer screenings.	20 months
Trends of overall skin cancer incidence and stage-specific-incidence		Up to 6 years (2012-2018)

Contacts/Locations Module

Overall Officials

Name	Affiliation	Role
Lynne H Robertson, MD, FRCPC	University of Calgary	Principal Investigator
Gordon E Searles, MD, FRCPC	University of Alberta	Principal Investigator
Eckhard W Breitbart, MD, PhD	Association of Dermatological Prevention, Germany	Principal Investigator

Condition Browse Module